Bassam Ghabach is an Oncology physician affiliated with Texas Christian University. OpenAlex indexes 44 publications with 445 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 S Main St
Fort Worth, TX 761044917
Telephone
817-927-3941Registry record last updated 29 Oct 2014.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- Regeneron Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
24.2%Phenothiazine13.3%Prochlorperazine Maleate100%Part D≥20 patientsAtypical Antipsychotic6.2%Olanzapine100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
22.5%Serotonin-3 Receptor Antagonist14.6%Ondansetron Odt54%Ondansetron Hcl46%Part D<11 patientsProton pump inhibitor7.9%Pantoprazole Sodium100%Part D<11 patientsCancer & immunology
15.8%Androgen Receptor Inhibitor8.8%Bicalutamide100%Part D<11 patientsAntimetabolite7.1%Hydroxyurea100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune Checkpoint Inhibitor Outcomes in NSCLC Across Populations and Practice Settings
JTO Clinical and Research Reports
2026 - Comparative effectiveness of treatment approaches for early invasive breast cancer
Annals of Epidemiology
2024 - Identification and Treatment of Lung Cancer Oncogenic Drivers in a Diverse Safety Net Setting
Clinical Lung Cancer
2024 - Outcomes of Patients With Acute Lymphoblastic Leukemia Treated at a Safety-Net Hospital
Clinical Lymphoma Myeloma & Leukemia
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Raphael Schiffmann, MD
Texas Christian University
Dale Stovall, MD
Texas Christian University
John Crawford, MD
Texas Christian University
Stevan Gonzalez, MD
Texas Christian University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”